Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.

about

Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology

P2860

Q55246321-974828BE-8EBF-400C-840C-FEA69E4AA41A Q58695249-E09BE650-1A0B-4CE4-97BA-A269EE020802

P2860

Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.

Item

http://www.wikidata.org/entity/Q36321612

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Circulating tumor cell status ...... cer patients: a meta-analysis.

@ast

Circulating tumor cell status ...... cer patients: a meta-analysis.

@en

type

Item

label

Circulating tumor cell status ...... cer patients: a meta-analysis.

@ast

Circulating tumor cell status ...... cer patients: a meta-analysis.

@en

prefLabel

Circulating tumor cell status ...... cer patients: a meta-analysis.

@ast

Circulating tumor cell status ...... cer patients: a meta-analysis.

@en

P1476

Circulating tumor cell status ...... cer patients: a meta-analysis.

@en

P2093

Jun Jiang

http://www.w3.org/2001/XMLSchema#string

Qing Chen

http://www.w3.org/2001/XMLSchema#string

Wen-Ting Yan

http://www.w3.org/2001/XMLSchema#string

Xiang Cui

http://www.w3.org/2001/XMLSchema#string

Ya-Fei Li

http://www.w3.org/2001/XMLSchema#string

Yan Wang

http://www.w3.org/2001/XMLSchema#string

You-Hong Cui

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating tumor cells in the diagnosis and management of pancreatic cancer

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

A multicenter phase I-II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer.

International study on inter-reader variability for circulating tumor cells in breast cancer

Circulating tumor cells predict survival in early average-to-high risk breast cancer patients.

Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500

Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients.

New Approach for Interpreting Changes in Circulating Tumour Cells (CTC) for Evaluation of Treatment Effect in Metastatic Breast Cancer.

Pathological response and circulating tumor cell count identifies treated HER2+ inflammatory breast cancer patients with excellent prognosis: BEVERLY-2 survival data.

P2888

srep43464

P304

43464

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1038/SREP43464

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28337998

http://www.w3.org/2001/XMLSchema#string

P932

5364512

http://www.w3.org/2001/XMLSchema#string

Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.

about

P2860

P2860

Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P577

P698

P932